Fiorello Pharmaceuticals
New York, US · Founded 2014 · New York corporation
Founders & leadership
AH
Aaron HoffnungExecutive
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 1 round · 2015
▶$2.5MraisedJun 2015 · 11 investors · PharmaceuticalsRule 506(b)
▶$2.5MraisedJun 2015 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Aaron HoffnungExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Minimum investment
- $50K
- Sales commissions
- $204K
- Proceeds to insiders
- $125K
- Placement agents
- CASTLEOAK SECURITIES, LP
- First sale
- Jun 2015
- Incorporated
- Corporation, New York, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Fiorello Pharmaceuticals raised?
- Fiorello Pharmaceuticals has disclosed $2.5M raised across 1 round.
- Where is Fiorello Pharmaceuticals headquartered?
- Fiorello Pharmaceuticals is headquartered in New York, US.